Pharma company Corona Remedies IPO opens on December 8; sets the price band at Rs 1,008-1,062/share

Pharmaceutical company Corona Remedies, which is backed by private equity firm ChrysCapital, on Wednesday set a price range of Rs 1,008-1,062 per share for its upcoming initial public offering (IPO), valuing the company at nearly Rs 6,500 crore. The initial public offer of Rs 655.37 crore, which is entirely an Offer For Sale (OFS) by […]

Chryscapital gets CCI Knik to acquire majority stake in bakery chain Theobroma

Fair Trade Regulator Competition Commission has erased the proposal of its own Private Equity Major Chryscapital on Tuesday to acquire a majority interest in the Mumbai -based bakery chain Theobroma. Chryscapital acquires the importance in Theobroma through its affiliated companies, Infinity Partners, Aqua Investments LTD and Atreids Investments BV. “The proposed combination relates to the […]